NYSE:CNC
CENTENE CORP
A digital-native health plan provider delivering affordable coverage to millions of Americans via Medicaid and ACA markets.
Key Metrics
Investment Thesis
Bull Case
Centene's dominant market position in Medicaid provides a stable membership base with recurring premium revenue streams that are difficult for competitors to displace. The company's heavy investment in digital infrastructure offers long-term cost advantages over traditional legacy health plans, positioning it well for efficiency gains as the industry matures.
Bear Case
The drastic shift from profitability to a $6.68B net loss in 2025 raises serious concerns about sustainability and potential accounting irregularities that warrant deep due diligence before entry. High levels of current liabilities relative to assets and a significant retained earnings deficit indicate underlying financial stress that could jeopardize future liquidity.
About CENTENE CORP
Centene Corp operates as a leading managed health care organization serving over 15 million lives primarily through Medicaid, Medicare Advantage, and ACA marketplace plans. The company leverages its digital-first technology platform to deliver cost-efficient healthcare services across the United States, focusing on value-based care models.
Analysis
Management Discussion
The company reported a significant net loss of $6.68B in 2025, a sharp reversal from profitable years between 2022 and 2024 where earnings grew steadily. Despite revenue surging to $194.78B, the massive non-cash adjustments of $11.30B and high operating expenses suggest complex accounting environments or one-time charges distorting reported profitability.
Industry Overview
The U.S. managed care industry is undergoing rapid consolidation as traditional insurers struggle with rising medical costs and regulatory pressures, creating an opening for agile, tech-focused disruptors. Government programs like Medicaid remain the largest payer segment, driving volume but constraining margins through strict rate-setting mechanisms and quality metrics.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $144.55B | $154.00B | $163.07B | $194.78B |
| Cost of Revenue | $7.03B | $3.56B | $2.73B | $2.67B |
| Gross Profit | $137.51B | $17.64B | $17.07B | $14.21B |
| Operating Expenses | $136.20B | $14.71B | $13.89B | $21.83B |
| Operating Income | $1.32B | $2.93B | $3.17B | $-7.62B |
| G&A | $11.59B | $12.56B | $12.40B | $12.90B |
| Stock-Based Comp | $234.0M | $216.0M | $212.0M | $204.0M |
| D&A | $1.55B | $1.29B | $1.24B | $1.27B |
| Depreciation | $614.0M | $575.0M | $549.0M | $590.0M |
| Amortization | $817.0M | $718.0M | $692.0M | $685.0M |
| Other OpEx | $124.61B | $2.14B | $1.49B | $8.93B |
| Non-Operating Income | $644.0M | $668.0M | $1.08B | $895.0M |
| Interest Expense | $665.0M | $725.0M | — | — |
| Pre-Tax Income | $1.96B | $3.60B | $4.26B | $-6.73B |
| Income Tax | $760.0M | $899.0M | $963.0M | $-51.0M |
| Continuing Ops | $1.20B | $2.70B | $3.29B | $-6.68B |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $1.20B | $2.70B | $3.29B | $-6.68B |
| Minority Interest | $0 | $-3.0M | $-11.0M | $-3.0M |
| Net to Common | $1.20B | $2.70B | $3.31B | $-6.67B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $30.13B | $40.76B | $38.00B | $40.37B |
| Cash & Equivalents | $12.07B | $17.19B | $14.06B | $17.89B |
| Marketable Securities | $2.32B | $2.46B | $2.62B | $2.43B |
| Other Current Assets | $15.73B | $21.10B | $21.31B | $20.05B |
| Long-Term Assets | $46.74B | $43.88B | $44.45B | $36.38B |
| PP&E (Net) | $2.43B | $2.02B | $2.07B | $2.04B |
| Intangibles | $6.91B | $6.10B | $5.41B | $4.53B |
| Goodwill | $18.81B | $17.56B | $17.56B | $10.84B |
| Operating Leases | $2.55B | $396.0M | $359.0M | $317.0M |
| LT Investments | $14.68B | $16.29B | $17.43B | $17.04B |
| Other LT Assets | $820.0M | $692.0M | $773.0M | $708.0M |
| Total Assets | $76.87B | $84.64B | $82.44B | $76.75B |
| Current Liabilities | $28.46B | $36.72B | $34.26B | $36.70B |
| Current Debt | $82.0M | $119.0M | $110.0M | $50.0M |
| Current Leases | $180.0M | $168.0M | $158.0M | $146.0M |
| Deferred Revenue | $478.0M | $715.0M | $661.0M | $736.0M |
| Other Current Liab | $27.72B | $35.71B | $33.33B | $35.76B |
| Long-Term Liabilities | $24.17B | $21.97B | $21.67B | $20.00B |
| Long-Term Debt | $17.94B | $17.71B | $18.42B | $17.35B |
| LT Operating Leases | $3.13B | $880.0M | $738.0M | $615.0M |
| Other LT Liab | $3.10B | $3.38B | $2.51B | $2.03B |
| Total Liabilities | $52.63B | $58.69B | $55.94B | $56.69B |
| Shareholders' Equity | $24.24B | $25.96B | $26.51B | $20.06B |
| Retained Earnings | $9.34B | $12.04B | $15.35B | $8.67B |
| AOCI | $-1.13B | $-652.0M | $-504.0M | $-58.0M |
| Treasury Stock | $4.21B | $5.86B | — | — |
| Total L&E | $76.87B | $84.64B | $82.44B | $76.75B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $1.20B | $2.70B | $3.29B | $-6.68B |
| Non-Cash Adjustments | $-131.0M | $-2.77B | $-7.14B | $11.30B |
| Working Capital Changes | $5.19B | $8.13B | $4.00B | $463.0M |
| Cash from Operations | $6.26B | $8.05B | $154.0M | $5.09B |
| Capital Expenditures | $1.00B | $799.0M | $644.0M | $767.0M |
| Cash from Investing | $-2.92B | $-1.19B | $-1.05B | $472.0M |
| Debt Issuances | $360.0M | $2.33B | $1.30B | $750.0M |
| Debt Repayments | $1.49B | $2.32B | $622.0M | $1.90B |
| Share Buybacks | $3.10B | $1.63B | $3.12B | $475.0M |
| Cash from Financing | $-4.20B | $-1.66B | $-2.41B | $-1.62B |
| FX Effect | $-11.0M | $-32.0M | $8.0M | $0 |
| Net Change in Cash | $-868.0M | $5.17B | $-3.30B | $3.94B |
| Beginning Cash | $13.21B | $12.33B | $17.45B | $14.16B |
| Ending Cash | $12.33B | $17.45B | $14.16B | $17.96B |
Frequently Asked Questions
How does CENTENE CORP make money?
Medicaid programs serving state-specific populations, Medicare Advantage plans for seniors with chronic disease management, and Affordable Care Act (ACA) marketplace exchange plans offering diverse product lines.
What are the main risks for CNC?
Regulatory changes in Medicaid reimbursement rates or federal healthcare policy shifts impacting margins; potential for large-scale medical loss ratio increases due to unexpected claim costs; sensitivity to interest rate fluctuations affecting debt servicing costs given the high leverage profile.
What is CNC's competitive advantage?
Proprietary data-driven technology stack enabling real-time claims processing and member engagement; significant scale allowing negotiation of lower provider reimbursement rates; robust membership growth trajectory demonstrating market share expansion.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.